Airsculpt Technologies, Inc. (AIRS): Price and Financial Metrics


Airsculpt Technologies, Inc. (AIRS): $3.34

-0.05 (-1.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AIRS POWR Grades

  • Value is the dimension where AIRS ranks best; there it ranks ahead of 77.02% of US stocks.
  • The strongest trend for AIRS is in Growth, which has been heading down over the past 179 days.
  • AIRS ranks lowest in Momentum; there it ranks in the 7th percentile.

AIRS Stock Summary

  • AIRS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.52 -- higher than only 4.68% of US-listed equities with positive expected earnings growth.
  • AIRSCULPT TECHNOLOGIES INC's stock had its IPO on October 29, 2021, making it an older stock than merely 0.87% of US equities in our set.
  • Over the past twelve months, AIRS has reported earnings growth of -168.75%, putting it ahead of just 9.59% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to AIRSCULPT TECHNOLOGIES INC are PRPO, ONEM, WRBY, NRDY, and CUEN.
  • To dig deeper into the stock's financial statements, go to AIRS's page on browse-edgar?action=getcompany&CIK=0001870940.

AIRS Valuation Summary

  • In comparison to the median Healthcare stock, AIRS's EV/EBIT ratio is 38389.47% higher, now standing at 2925.2.
  • Over the past 12 months, AIRS's price/sales ratio has gone down 11.7.

Below are key valuation metrics over time for AIRS.

Stock Date P/S P/B P/E EV/EBIT
AIRS 2022-11-01 2.4 3.9 -61.8 2925.2
AIRS 2022-10-31 2.3 3.9 -60.8 2881.9
AIRS 2022-10-28 2.4 3.9 -61.3 2903.9
AIRS 2022-10-27 2.4 3.9 -61.4 2907.1
AIRS 2022-10-26 2.2 3.7 -57.7 2760.0
AIRS 2022-10-25 2.2 3.6 -56.7 2720.6

AIRS Stock Price Chart Interactive Chart >

Price chart for AIRS

AIRS Price/Volume Stats

Current price $3.34 52-week high $18.48
Prev. close $3.38 52-week low $2.69
Day low $3.25 Volume 52,700
Day high $3.38 Avg. volume 196,012
50-day MA $5.80 Dividend yield N/A
200-day MA $8.89 Market Cap 185.84M

Airsculpt Technologies, Inc. (AIRS) Company Bio


AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.


AIRS Latest News Stream


Event/Time News Detail
Loading, please wait...

AIRS Latest Social Stream


Loading social stream, please wait...

View Full AIRS Social Stream

Latest AIRS News From Around the Web

Below are the latest news stories about AIRSCULPT TECHNOLOGIES INC that investors may wish to consider to help them evaluate AIRS as an investment opportunity.

AirSculpt® Technologies, Inc. Expands to Toronto, Its First International Market

The premium body contouring provider is located in the charming Yorkville neighborhoodMIAMI BEACH, Fla., Nov. 23, 2022 (GLOBE NEWSWIRE) -- AirSculpt® Technologies, Inc., (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its first international Elite Body Sculpture location in Toronto, Canada. AirSculpt® is a best in class, next-generation body contouring treatment designed to optimize both comfort and precision, ava

Yahoo | November 23, 2022

Morgan Stanley Sticks to Its Hold Rating for Airsculpt Technologies, Inc. (AIRS)

In a report released today, Simeon Gutman from Morgan Stanley maintained a Hold rating on Airsculpt Technologies, Inc. (AIRS - Research Report), with a price target of $7.00. The company's shares opened today at $2.76.Gutman covers the Consumer Goods sector, focusing on stocks such as O'Reilly Auto, Walmart, and Costco. According to TipRanks, Gutman has an average return of 0.7% and a 58.46% success rate on recommended stocks. In addition to Morgan Stanley, Airsculpt Technologies, Inc. also received a Hold from Piper Sandler's Korinne Wolfmeyer in a report issued on November 11. However, yesterday, Raymond James maintained a Buy rating on Airsculpt Technologies, Inc. (NASDAQ: AIRS).

Austin Angelo on TipRanks | November 15, 2022

Analysts’ Top Healthcare Picks: Airsculpt Technologies, Inc. (AIRS), Agenus (AGEN)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Airsculpt Technologies, Inc. (AIRS – Research Report) and Agenus (AGEN – Research Report) with bullish sentiments. Airsculpt Technologies, Inc. (AIRS) SVB Securities analyst Whit Mayo maintained a Buy rating on Airsculpt Technologies, Inc. today and set a price target of $8.00. The company's shares closed last Friday at $3.28, close to its 52-week low of $3.23. According to TipRanks.

Christine Brown on TipRanks | November 14, 2022

AirSculpt Technologies Third Quarter 2022 Earnings: Misses Expectations

AirSculpt Technologies ( NASDAQ:AIRS ) Third Quarter 2022 Results Key Financial Results Revenue: US$38.9m (up 12% from...

Yahoo | November 13, 2022

AirSculpt Plummets After Failing to Carve Out a Profit in Q3

Shares of AirSculpt Technologies (NASDAQ: AIRS) were in freefall in pre-market trading on Friday after the provider of body contouring procedures reported disappointing Q3 earnings. The company reported revenues of $38.9 million in Q3, up 12.2% year-over-year but still missed estimates by $5.1 million. AirSculpt's loss came in at $0.13 per share while analysts were expecting a profit of $0.02. For FY22, AIRS also reduced its revenue outlook and now expects it to be between $168 million and 170 million and lowered Adjusted EBITDA outlook to range from $45 million to $47 million.

Shrilekha Pethe on TipRanks | November 11, 2022

Read More 'AIRS' Stories Here

AIRS Price Returns

1-mo -51.24%
3-mo -62.68%
6-mo N/A
1-year -72.28%
3-year N/A
5-year N/A
YTD -80.57%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7904 seconds.